Daphnetin inhibits proliferation and inflammatory response in human HaCaT keratinocytes and ameliorates imiquimod-induced psoriasis-like skin lesion in mice
Psoriasis is a common chronic inflammatory skin disease. Keratinocytes hyperproliferation and excessive inflammatory response contribute to psoriasis pathogenesis. The agents able to attenuate keratinocytes hyperproliferation and excessive inflammatory response are considered to be potentially usefu...
Saved in:
| Published in | Biological research Vol. 53; no. 1; pp. 48 - 12 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
BioMed Central Ltd
20.10.2020
BioMed Central Sociedad de Biología de Chile BMC |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Psoriasis is a common chronic inflammatory skin disease. Keratinocytes hyperproliferation and excessive inflammatory response contribute to psoriasis pathogenesis. The agents able to attenuate keratinocytes hyperproliferation and excessive inflammatory response are considered to be potentially useful for psoriasis treatment. Daphnetin exhibits broad bioactivities including anti-proliferation and anti-inflammatory. This study aims to evaluate the anti-psoriatic potential of daphnetin in vitro and in vivo, and explore underlying mechanisms.
HaCaT keratinocytes was stimulated with the mixture of IL-17A, IL-22, oncostatin M, IL-1α, and TNF-α (M5) to establish psoriatic keratinocyte model in vitro. Cell viability was measured using Cell Counting Kit-8 (CCK-8). Quantitative Real-Time PCR (qRT-PCR) was performed to measure the mRNA levels of hyperproliferative marker gene keratin 6 (KRT6), differentiation marker gene keratin 1 (KRT1) and inflammatory factors IL-1β, IL-6, IL-8, TNF-α, IL-23A and MCP-1. Western blotting was used to detect the protein levels of p65 and p-p65. Indirect immunofluorescence assay (IFA) was carried out to detect p65 nuclear translocation. Imiquimod (IMQ) was used to construct psoriasis-like mouse model. Psoriasis severity (erythema, scaling) was scored based on Psoriasis Area Severity Index (PASI). Hematoxylin and eosin (H&E) staining was performed to examine histological change in skin lesion. The expression of inflammatory factors including IL-6, TNF-α, IL-23A and IL-17A in skin lesion was measured by qRT-PCR.
Daphnetin attenuated M5-induced hyperproliferation in HaCaT keratinocytes. M5 stimulation significantly upregulated mRNA levels of IL-1β, IL-6, IL-8, TNF-α, IL-23A and MCP-1. However, daphnetin treatment partially attenuated the upregulation of those inflammatory cytokines. Daphnetin was found to be able to inhibit p65 phosphorylation and nuclear translocation in HaCaT keratinocytes. In addition, daphnetin significantly ameliorate the severity of skin lesion (erythema, scaling and epidermal thickness, inflammatory cell infiltration) in IMQ-induced psoriasis-like mouse model. Daphnetin treatment attenuated IMQ-induced upregulation of inflammatory cytokines including IL-6, IL-23A and IL-17A in skin lesion of mice.
Daphnetin was able to attenuate proliferation and inflammatory response induced by M5 in HaCaT keratinocytes through suppression of NF-κB signaling pathway. Daphnetin could ameliorate the severity of skin lesion and improve inflammation status in IMQ-induced psoriasis-like mouse model. Daphnetin could be an attractive candidate for future development as an anti-psoriatic agent. |
|---|---|
| AbstractList | Psoriasis is a common chronic inflammatory skin disease. Keratinocytes hyperproliferation and excessive inflammatory response contribute to psoriasis pathogenesis. The agents able to attenuate keratinocytes hyperproliferation and excessive inflammatory response are considered to be potentially useful for psoriasis treatment. Daphnetin exhibits broad bioactivities including anti-proliferation and anti-inflammatory. This study aims to evaluate the anti-psoriatic potential of daphnetin in vitro and in vivo, and explore underlying mechanisms.
HaCaT keratinocytes was stimulated with the mixture of IL-17A, IL-22, oncostatin M, IL-1α, and TNF-α (M5) to establish psoriatic keratinocyte model in vitro. Cell viability was measured using Cell Counting Kit-8 (CCK-8). Quantitative Real-Time PCR (qRT-PCR) was performed to measure the mRNA levels of hyperproliferative marker gene keratin 6 (KRT6), differentiation marker gene keratin 1 (KRT1) and inflammatory factors IL-1β, IL-6, IL-8, TNF-α, IL-23A and MCP-1. Western blotting was used to detect the protein levels of p65 and p-p65. Indirect immunofluorescence assay (IFA) was carried out to detect p65 nuclear translocation. Imiquimod (IMQ) was used to construct psoriasis-like mouse model. Psoriasis severity (erythema, scaling) was scored based on Psoriasis Area Severity Index (PASI). Hematoxylin and eosin (H&E) staining was performed to examine histological change in skin lesion. The expression of inflammatory factors including IL-6, TNF-α, IL-23A and IL-17A in skin lesion was measured by qRT-PCR.
Daphnetin attenuated M5-induced hyperproliferation in HaCaT keratinocytes. M5 stimulation significantly upregulated mRNA levels of IL-1β, IL-6, IL-8, TNF-α, IL-23A and MCP-1. However, daphnetin treatment partially attenuated the upregulation of those inflammatory cytokines. Daphnetin was found to be able to inhibit p65 phosphorylation and nuclear translocation in HaCaT keratinocytes. In addition, daphnetin significantly ameliorate the severity of skin lesion (erythema, scaling and epidermal thickness, inflammatory cell infiltration) in IMQ-induced psoriasis-like mouse model. Daphnetin treatment attenuated IMQ-induced upregulation of inflammatory cytokines including IL-6, IL-23A and IL-17A in skin lesion of mice.
Daphnetin was able to attenuate proliferation and inflammatory response induced by M5 in HaCaT keratinocytes through suppression of NF-κB signaling pathway. Daphnetin could ameliorate the severity of skin lesion and improve inflammation status in IMQ-induced psoriasis-like mouse model. Daphnetin could be an attractive candidate for future development as an anti-psoriatic agent. Psoriasis is a common chronic inflammatory skin disease. Keratinocytes hyperproliferation and excessive inflammatory response contribute to psoriasis pathogenesis. The agents able to attenuate keratinocytes hyperproliferation and excessive inflammatory response are considered to be potentially useful for psoriasis treatment. Daphnetin exhibits broad bioactivities including anti-proliferation and anti-inflammatory. This study aims to evaluate the anti-psoriatic potential of daphnetin in vitro and in vivo, and explore underlying mechanisms.BACKGROUNDPsoriasis is a common chronic inflammatory skin disease. Keratinocytes hyperproliferation and excessive inflammatory response contribute to psoriasis pathogenesis. The agents able to attenuate keratinocytes hyperproliferation and excessive inflammatory response are considered to be potentially useful for psoriasis treatment. Daphnetin exhibits broad bioactivities including anti-proliferation and anti-inflammatory. This study aims to evaluate the anti-psoriatic potential of daphnetin in vitro and in vivo, and explore underlying mechanisms.HaCaT keratinocytes was stimulated with the mixture of IL-17A, IL-22, oncostatin M, IL-1α, and TNF-α (M5) to establish psoriatic keratinocyte model in vitro. Cell viability was measured using Cell Counting Kit-8 (CCK-8). Quantitative Real-Time PCR (qRT-PCR) was performed to measure the mRNA levels of hyperproliferative marker gene keratin 6 (KRT6), differentiation marker gene keratin 1 (KRT1) and inflammatory factors IL-1β, IL-6, IL-8, TNF-α, IL-23A and MCP-1. Western blotting was used to detect the protein levels of p65 and p-p65. Indirect immunofluorescence assay (IFA) was carried out to detect p65 nuclear translocation. Imiquimod (IMQ) was used to construct psoriasis-like mouse model. Psoriasis severity (erythema, scaling) was scored based on Psoriasis Area Severity Index (PASI). Hematoxylin and eosin (H&E) staining was performed to examine histological change in skin lesion. The expression of inflammatory factors including IL-6, TNF-α, IL-23A and IL-17A in skin lesion was measured by qRT-PCR.METHODSHaCaT keratinocytes was stimulated with the mixture of IL-17A, IL-22, oncostatin M, IL-1α, and TNF-α (M5) to establish psoriatic keratinocyte model in vitro. Cell viability was measured using Cell Counting Kit-8 (CCK-8). Quantitative Real-Time PCR (qRT-PCR) was performed to measure the mRNA levels of hyperproliferative marker gene keratin 6 (KRT6), differentiation marker gene keratin 1 (KRT1) and inflammatory factors IL-1β, IL-6, IL-8, TNF-α, IL-23A and MCP-1. Western blotting was used to detect the protein levels of p65 and p-p65. Indirect immunofluorescence assay (IFA) was carried out to detect p65 nuclear translocation. Imiquimod (IMQ) was used to construct psoriasis-like mouse model. Psoriasis severity (erythema, scaling) was scored based on Psoriasis Area Severity Index (PASI). Hematoxylin and eosin (H&E) staining was performed to examine histological change in skin lesion. The expression of inflammatory factors including IL-6, TNF-α, IL-23A and IL-17A in skin lesion was measured by qRT-PCR.Daphnetin attenuated M5-induced hyperproliferation in HaCaT keratinocytes. M5 stimulation significantly upregulated mRNA levels of IL-1β, IL-6, IL-8, TNF-α, IL-23A and MCP-1. However, daphnetin treatment partially attenuated the upregulation of those inflammatory cytokines. Daphnetin was found to be able to inhibit p65 phosphorylation and nuclear translocation in HaCaT keratinocytes. In addition, daphnetin significantly ameliorate the severity of skin lesion (erythema, scaling and epidermal thickness, inflammatory cell infiltration) in IMQ-induced psoriasis-like mouse model. Daphnetin treatment attenuated IMQ-induced upregulation of inflammatory cytokines including IL-6, IL-23A and IL-17A in skin lesion of mice.RESULTSDaphnetin attenuated M5-induced hyperproliferation in HaCaT keratinocytes. M5 stimulation significantly upregulated mRNA levels of IL-1β, IL-6, IL-8, TNF-α, IL-23A and MCP-1. However, daphnetin treatment partially attenuated the upregulation of those inflammatory cytokines. Daphnetin was found to be able to inhibit p65 phosphorylation and nuclear translocation in HaCaT keratinocytes. In addition, daphnetin significantly ameliorate the severity of skin lesion (erythema, scaling and epidermal thickness, inflammatory cell infiltration) in IMQ-induced psoriasis-like mouse model. Daphnetin treatment attenuated IMQ-induced upregulation of inflammatory cytokines including IL-6, IL-23A and IL-17A in skin lesion of mice.Daphnetin was able to attenuate proliferation and inflammatory response induced by M5 in HaCaT keratinocytes through suppression of NF-κB signaling pathway. Daphnetin could ameliorate the severity of skin lesion and improve inflammation status in IMQ-induced psoriasis-like mouse model. Daphnetin could be an attractive candidate for future development as an anti-psoriatic agent.CONCLUSIONSDaphnetin was able to attenuate proliferation and inflammatory response induced by M5 in HaCaT keratinocytes through suppression of NF-κB signaling pathway. Daphnetin could ameliorate the severity of skin lesion and improve inflammation status in IMQ-induced psoriasis-like mouse model. Daphnetin could be an attractive candidate for future development as an anti-psoriatic agent. Background Psoriasis is a common chronic inflammatory skin disease. Keratinocytes hyperproliferation and excessive inflammatory response contribute to psoriasis pathogenesis. The agents able to attenuate keratinocytes hyperproliferation and excessive inflammatory response are considered to be potentially useful for psoriasis treatment. Daphnetin exhibits broad bioactivities including anti-proliferation and anti-inflammatory. This study aims to evaluate the anti-psoriatic potential of daphnetin in vitro and in vivo, and explore underlying mechanisms. Methods HaCaT keratinocytes was stimulated with the mixture of IL-17A, IL-22, oncostatin M, IL-1α, and TNF-α (M5) to establish psoriatic keratinocyte model in vitro. Cell viability was measured using Cell Counting Kit-8 (CCK-8). Quantitative Real-Time PCR (qRT-PCR) was performed to measure the mRNA levels of hyperproliferative marker gene keratin 6 (KRT6), differentiation marker gene keratin 1 (KRT1) and inflammatory factors IL-1β, IL-6, IL-8, TNF-α, IL-23A and MCP-1. Western blotting was used to detect the protein levels of p65 and p-p65. Indirect immunofluorescence assay (IFA) was carried out to detect p65 nuclear translocation. Imiquimod (IMQ) was used to construct psoriasis-like mouse model. Psoriasis severity (erythema, scaling) was scored based on Psoriasis Area Severity Index (PASI). Hematoxylin and eosin (H&E) staining was performed to examine histological change in skin lesion. The expression of inflammatory factors including IL-6, TNF-α, IL-23A and IL-17A in skin lesion was measured by qRT-PCR. Results Daphnetin attenuated M5-induced hyperproliferation in HaCaT keratinocytes. M5 stimulation significantly upregulated mRNA levels of IL-1β, IL-6, IL-8, TNF-α, IL-23A and MCP-1. However, daphnetin treatment partially attenuated the upregulation of those inflammatory cytokines. Daphnetin was found to be able to inhibit p65 phosphorylation and nuclear translocation in HaCaT keratinocytes. In addition, daphnetin significantly ameliorate the severity of skin lesion (erythema, scaling and epidermal thickness, inflammatory cell infiltration) in IMQ-induced psoriasis-like mouse model. Daphnetin treatment attenuated IMQ-induced upregulation of inflammatory cytokines including IL-6, IL-23A and IL-17A in skin lesion of mice. Conclusions Daphnetin was able to attenuate proliferation and inflammatory response induced by M5 in HaCaT keratinocytes through suppression of NF-κB signaling pathway. Daphnetin could ameliorate the severity of skin lesion and improve inflammation status in IMQ-induced psoriasis-like mouse model. Daphnetin could be an attractive candidate for future development as an anti-psoriatic agent. Abstract Background Psoriasis is a common chronic inflammatory skin disease. Keratinocytes hyperproliferation and excessive inflammatory response contribute to psoriasis pathogenesis. The agents able to attenuate keratinocytes hyperproliferation and excessive inflammatory response are considered to be potentially useful for psoriasis treatment. Daphnetin exhibits broad bioactivities including anti-proliferation and anti-inflammatory. This study aims to evaluate the anti-psoriatic potential of daphnetin in vitro and in vivo, and explore underlying mechanisms. Methods HaCaT keratinocytes was stimulated with the mixture of IL-17A, IL-22, oncostatin M, IL-1α, and TNF-α (M5) to establish psoriatic keratinocyte model in vitro. Cell viability was measured using Cell Counting Kit-8 (CCK-8). Quantitative Real-Time PCR (qRT-PCR) was performed to measure the mRNA levels of hyperproliferative marker gene keratin 6 (KRT6), differentiation marker gene keratin 1 (KRT1) and inflammatory factors IL-1β, IL-6, IL-8, TNF-α, IL-23A and MCP-1. Western blotting was used to detect the protein levels of p65 and p-p65. Indirect immunofluorescence assay (IFA) was carried out to detect p65 nuclear translocation. Imiquimod (IMQ) was used to construct psoriasis-like mouse model. Psoriasis severity (erythema, scaling) was scored based on Psoriasis Area Severity Index (PASI). Hematoxylin and eosin (H&E) staining was performed to examine histological change in skin lesion. The expression of inflammatory factors including IL-6, TNF-α, IL-23A and IL-17A in skin lesion was measured by qRT-PCR. Results Daphnetin attenuated M5-induced hyperproliferation in HaCaT keratinocytes. M5 stimulation significantly upregulated mRNA levels of IL-1β, IL-6, IL-8, TNF-α, IL-23A and MCP-1. However, daphnetin treatment partially attenuated the upregulation of those inflammatory cytokines. Daphnetin was found to be able to inhibit p65 phosphorylation and nuclear translocation in HaCaT keratinocytes. In addition, daphnetin significantly ameliorate the severity of skin lesion (erythema, scaling and epidermal thickness, inflammatory cell infiltration) in IMQ-induced psoriasis-like mouse model. Daphnetin treatment attenuated IMQ-induced upregulation of inflammatory cytokines including IL-6, IL-23A and IL-17A in skin lesion of mice. Conclusions Daphnetin was able to attenuate proliferation and inflammatory response induced by M5 in HaCaT keratinocytes through suppression of NF-κB signaling pathway. Daphnetin could ameliorate the severity of skin lesion and improve inflammation status in IMQ-induced psoriasis-like mouse model. Daphnetin could be an attractive candidate for future development as an anti-psoriatic agent. Abstract Background: Psoriasis is a common chronic inflammatory skin disease. Keratinocytes hyperproliferation and excessive inflammatory response contribute to psoriasis pathogenesis. The agents able to attenuate keratinocytes hyper-proliferation and excessive inflammatory response are considered to be potentially useful for psoriasis treatment. Daphnetin exhibits broad bioactivities including anti-proliferation and anti-inflammatory. This study aims to evaluate the anti-psoriatic potential of daphnetin in vitro and in vivo, and explore underlying mechanisms. Methods: HaCaT keratinocytes was stimulated with the mixture of IL-17A, IL-22, oncostatin M, IL-1α, and TNF-α (M5) to establish psoriatic keratinocyte model in vitro. Cell viability was measured using Cell Counting Kit-8 (CCK-8). Quantitative Real-Time PCR (qRT-PCR) was performed to measure the mRNA levels of hyperproliferative marker gene keratin 6 (KRT6), differentiation marker gene keratin 1 (KRT1) and inflammatory factors IL-1β, IL-6, IL-8, TNF-α, IL-23A and MCP-1. Western blotting was used to detect the protein levels of p65 and p-p65. Indirect immunofluorescence assay (IFA) was carried out to detect p65 nuclear translocation. Imiquimod (IMQ) was used to construct psoriasis-like mouse model. Psoriasis severity (erythema, scaling) was scored based on Psoriasis Area Severity Index (PASI). Hematoxylin and eosin (H&E) staining was performed to examine histological change in skin lesion. The expression of inflammatory factors including IL-6, TNF-α, IL-23A and IL-17A in skin lesion was measured by qRT-PCR. Results: Daphnetin attenuated M5-induced hyperproliferation in HaCaT keratinocytes. M5 stimulation significantly upregulated mRNA levels of IL-1β, IL-6, IL-8, TNF-α, IL-23A and MCP-1. However, daphnetin treatment partially attenuated the upregulation of those inflammatory cytokines. Daphnetin was found to be able to inhibit p65 phosphorylation and nuclear translocation in HaCaT keratinocytes. In addition, daphnetin significantly ameliorate the severity of skin lesion (erythema, scaling and epidermal thickness, inflammatory cell infiltration) in IMQ-induced psoriasis-like mouse model. Daphnetin treatment attenuated IMQ-induced upregulation of inflammatory cytokines including IL-6, IL-23A and IL-17A in skin lesion of mice. Conclusions: Daphnetin was able to attenuate proliferation and inflammatory response induced by M5 in HaCaT keratinocytes through suppression of NF-κB signaling pathway. Daphnetin could ameliorate the severity of skin lesion and improve inflammation status in IMQ-induced psoriasis-like mouse model. Daphnetin could be an attractive candidate for future development as an anti-psoriatic agent. |
| ArticleNumber | 48 |
| Audience | Academic |
| Author | Qi, Qi Chen, Fangru Mi, Jing Gao, Jintao Fang, Huanan Yang, Mengjuan |
| AuthorAffiliation | Affiliated Hospital of Guilin Medical University Guilin Medical University |
| AuthorAffiliation_xml | – name: Guilin Medical University – name: Affiliated Hospital of Guilin Medical University |
| Author_xml | – sequence: 1 givenname: Jintao orcidid: 0000-0002-3991-9706 surname: Gao fullname: Gao, Jintao – sequence: 2 givenname: Fangru surname: Chen fullname: Chen, Fangru – sequence: 3 givenname: Huanan surname: Fang fullname: Fang, Huanan – sequence: 4 givenname: Jing surname: Mi fullname: Mi, Jing – sequence: 5 givenname: Qi surname: Qi fullname: Qi, Qi – sequence: 6 givenname: Mengjuan surname: Yang fullname: Yang, Mengjuan |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33081840$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9U8tu1DAUjVARfcAPsECR2MAixa_YzgapKo9WqoREy9pynJsZt4k9tRNE_4WP5c5MWzoscBZ2rs85vs_DYi_EAEXxmpJjSrX8kAWRdVMRRipCOJUVeVYcEEVVJZlWe0_O-8VhzteEsJow-aLY55xoqgU5KH5_sqtlgMmH0oelb_2Uy1WKg-8h2cnHUNrQ4VU_2HG0U0x3ZYK8iiEDWsvlPNpQntlTe1XebBghursJ8oZmRxh8RCv--9Hfzn6MXeVDNzvoylWOydvsczX4GyjzDeoNkNdv4mn0Dl4Wz3s7ZHh1vx8VP758vjo9qy6-fT0_PbmonORyqnoiGlCUgGt7W9dSOtoobfta9aLjwlpdC2FJq2rHKG0dB91D39QcmG257flRcb7V7aK9NqvkR5vuTLTebAwxLYxNk3cDmLrR0NJW6Zp1QjXIVyijBOFKYyE4ah1vtbLzMERzHecU0HlzidWQplESYYzgolgPXiPh45awmtsROgdhSnbY8WL3JvilWcSfRtVKYmQo8O5eIMXbGfJkRp8dDIMNEOdsmKhZo4lgEqFv_4E-useExI6gYiN4j1pYjBhrH_FdtxY1J5I3hOqGqr-B7qDw6wBrh53ae7TvEN7vEBAzwa9pYeeczfnl913sm6dJeczGQ-MiQG8BLsWcE_TG-WnTsOiFHwwlZj0jZjsjBjNuNjNi1lT2D_VB_T-kP6YgEh4 |
| CitedBy_id | crossref_primary_10_1016_j_actbio_2024_06_006 crossref_primary_10_1021_acsbiomaterials_4c01649 crossref_primary_10_2147_JIR_S500822 crossref_primary_10_1007_s10753_023_01805_6 crossref_primary_10_3390_cells12242795 crossref_primary_10_1080_02648725_2023_2194092 crossref_primary_10_1007_s10753_024_01995_7 crossref_primary_10_1007_s00005_023_00685_w crossref_primary_10_1016_j_ajpath_2024_01_014 crossref_primary_10_1016_j_ijbiomac_2023_125239 crossref_primary_10_3390_ijms22137145 crossref_primary_10_1016_j_intimp_2024_113932 crossref_primary_10_3390_molecules27041412 crossref_primary_10_3390_molecules27082447 crossref_primary_10_1016_j_intimp_2023_111033 crossref_primary_10_3389_fnut_2025_1546932 crossref_primary_10_1016_j_advms_2024_03_005 crossref_primary_10_1016_j_intimp_2025_114387 crossref_primary_10_1016_j_jep_2022_115195 crossref_primary_10_1021_acs_jmedchem_4c01804 crossref_primary_10_1016_j_intimp_2025_114064 crossref_primary_10_3390_ijms26031310 crossref_primary_10_1186_s40364_024_00663_0 crossref_primary_10_1038_s41419_024_06545_5 crossref_primary_10_1002_ptr_8426 crossref_primary_10_1016_j_jff_2021_104433 crossref_primary_10_1016_j_intimp_2022_109632 crossref_primary_10_3389_fimmu_2023_1265517 crossref_primary_10_3390_cells13161398 crossref_primary_10_1016_j_bmc_2023_117420 crossref_primary_10_1177_09731296231198931 crossref_primary_10_2147_IJN_S443812 crossref_primary_10_3390_nu15040883 crossref_primary_10_18632_aging_203287 crossref_primary_10_3390_molecules29112410 crossref_primary_10_2147_CCID_S414633 crossref_primary_10_1177_19458924221124363 crossref_primary_10_1007_s00403_024_03668_9 crossref_primary_10_1016_j_biochi_2024_10_010 crossref_primary_10_1016_j_xjidi_2024_100273 crossref_primary_10_2147_CCID_S430621 crossref_primary_10_1016_j_intimp_2025_114036 crossref_primary_10_1097_ICO_0000000000003454 crossref_primary_10_1111_exd_14997 crossref_primary_10_1186_s40659_023_00454_1 crossref_primary_10_1016_j_acthis_2024_152166 crossref_primary_10_1016_j_jphotobiol_2024_112937 crossref_primary_10_1016_j_intimp_2021_108434 crossref_primary_10_3389_fbioe_2022_900274 crossref_primary_10_1111_1346_8138_16874 crossref_primary_10_1016_j_ijpharm_2023_122591 crossref_primary_10_1002_iid3_1303 crossref_primary_10_1007_s00403_024_03550_8 crossref_primary_10_1080_17435889_2025_2480047 crossref_primary_10_2147_CCID_S435624 crossref_primary_10_1016_j_ijpharm_2021_120762 crossref_primary_10_1016_j_jsps_2023_04_007 crossref_primary_10_1038_s41401_024_01449_8 crossref_primary_10_3390_ijms232416000 crossref_primary_10_3389_fphar_2022_1067051 crossref_primary_10_3390_foods12112107 crossref_primary_10_1016_j_eujim_2022_102170 crossref_primary_10_1007_s00403_022_02453_w crossref_primary_10_1016_j_fbio_2025_106354 crossref_primary_10_1007_s11655_023_3599_y crossref_primary_10_3389_fimmu_2024_1432846 crossref_primary_10_1007_s10787_025_01708_y crossref_primary_10_1016_j_ejmech_2024_116930 crossref_primary_10_1016_j_imlet_2024_106949 crossref_primary_10_1016_j_phrs_2025_107624 crossref_primary_10_1186_s12964_023_01041_3 crossref_primary_10_4103_apjtb_apjtb_347_24 crossref_primary_10_1016_j_cellsig_2025_111706 crossref_primary_10_1016_j_jddst_2022_103450 crossref_primary_10_1016_j_biopha_2024_117647 crossref_primary_10_1016_j_ijbiomac_2024_135404 crossref_primary_10_3389_fphar_2025_1520392 crossref_primary_10_1016_j_intimp_2024_113785 crossref_primary_10_3390_pharmaceutics16010040 crossref_primary_10_1080_08923973_2022_2093742 crossref_primary_10_7717_peerj_17027 crossref_primary_10_1007_s43440_021_00261_z crossref_primary_10_1155_2022_5978271 crossref_primary_10_1016_j_bbamcr_2024_119689 crossref_primary_10_3390_pharmaceutics15082165 crossref_primary_10_1002_tox_23837 crossref_primary_10_1016_j_bbrc_2022_09_115 crossref_primary_10_1016_j_biopha_2024_116705 crossref_primary_10_1007_s00210_024_03461_5 crossref_primary_10_1016_j_jep_2023_116746 crossref_primary_10_3389_fphar_2022_993562 crossref_primary_10_1002_kjm2_12683 crossref_primary_10_1155_2023_4878774 crossref_primary_10_1016_j_jddst_2022_103895 |
| Cites_doi | 10.1038/jid.2013.182 10.1038/nature05505 10.1038/sj.jid.5700008 10.4049/jimmunol.175.4.2721 10.1128/MCB.19.10.7181 10.1016/j.biopha.2016.05.028 10.4049/jimmunol.0802999 10.1371/journal.pone.0101937 10.1021/jf503667v 10.1371/journal.pone.0176823 10.1039/C8RA05583A 10.1111/1523-1747.ep12363613 10.1016/j.cell.2008.01.020 10.1016/j.pharep.2017.04.006 10.1142/S0192415X16500105 10.1016/j.jaci.2017.07.004 10.1016/S0140-6736(14)61909-7 10.1371/journal.pone.0096502 10.1056/NEJMra0804595 10.4049/jimmunol.0900521 10.1016/j.clindermatol.2007.08.013 10.2174/1568010054022033 10.1101/gad.1228704 10.1016/j.jdermsci.2012.11.002 10.1371/journal.pone.0067078 10.3892/etm.2013.1054 10.1016/j.jid.2018.06.184 10.1038/nrdp.2016.82 10.3892/etm.2016.3971 10.4049/jimmunol.0902464 10.4061/2011/908468 10.1084/jem.20060244 10.3109/09546634.2013.782091 10.1111/1523-1747.ep12555613 10.4049/jimmunol.176.3.1431 10.1111/j.0022-202X.2005.23735.x 10.1007/s11010-015-2641-6 10.1111/1523-1747.ep12478128 10.1038/s41598-018-26996-z 10.1038/jid.2009.59 10.1111/bjd.14481 10.1007/BF00371784 10.1006/meth.2001.1262 10.1016/j.it.2012.11.005 |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2020 BioMed Central Ltd. 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2020 This work is licensed under a Creative Commons Attribution 4.0 International License. |
| Copyright_xml | – notice: COPYRIGHT 2020 BioMed Central Ltd. – notice: 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2020 – notice: This work is licensed under a Creative Commons Attribution 4.0 International License. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM ISR INF 3V. 7X7 7XB 88E 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 5PM GPN DOA |
| DOI | 10.1186/s40659-020-00316-0 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Science Gale OneFile: Informe Academico ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection Health & Medical Collection (Alumni Edition) Medical Database Biological Science Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) SciELO DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 0717-6287 |
| EndPage | 12 |
| ExternalDocumentID | oai_doaj_org_article_598eb1b7852d479ab373e27403780203 S0716_97602020000100235 PMC7576854 A639018917 33081840 10_1186_s40659_020_00316_0 |
| Genre | Journal Article |
| GrantInformation_xml | – fundername: Natural Science Foundation of Guangxi Zhuang Autonomous Region grantid: 2016GXNSFBA380146 – fundername: National Nature Science Foundation of China grantid: 31860314 – fundername: Natural Science Foundation of Guangxi Zhuang Autonomous Region grantid: 2018GXNSFAA281041 – fundername: ; grantid: 2018GXNSFAA281041; 2016GXNSFBA380146 – fundername: ; grantid: 31860314 |
| GroupedDBID | --- 0R~ 23N 2WC 4.4 53G 5GY 7X7 88E 8FE 8FH 8FI 8FJ AAFWJ AAJSJ AASML AAYXX ABUWG ABXHO ACGFO ACGFS ACPRK ADBBV ADRAZ ADUKV AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS APOWU ASPBG AVWKF AZFZN BAPOH BAWUL BBNVY BCNDV BENPR BFQNJ BHPHI BMC BPHCQ BVXVI C6C CCPQU CITATION DIK DU5 E3Z EBLON EBS ECGQY F5P FYUFA GROUPED_DOAJ GX1 HCIFZ HMCUK HYE IAO IHR INF ISR ITC KQ8 LK8 M1P M48 M7P OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSD RSV SCD SOJ TR2 UKHRP XSB CGR CUY CVF ECM EIF NPM PJZUB PPXIY PQGLB PMFND 3V. 7XB 8FK AZQEC DWQXO GNUQQ K9. PKEHL PQEST PQUKI PRINS 7X8 5PM AHSBF C1A EJD GPN H13 PUEGO |
| ID | FETCH-LOGICAL-c636t-f049e710ecbfa5566c1978af57f4d34aa8544a0b75c211bc3e8fef953e2ab3af3 |
| IEDL.DBID | M48 |
| ISSN | 0717-6287 0716-9760 |
| IngestDate | Wed Aug 27 00:54:04 EDT 2025 Tue Aug 19 13:45:21 EDT 2025 Thu Aug 21 14:11:00 EDT 2025 Fri Jul 11 04:50:22 EDT 2025 Fri Jul 25 11:58:57 EDT 2025 Tue Jun 17 21:30:05 EDT 2025 Tue Jun 10 20:46:15 EDT 2025 Fri Jun 27 04:25:38 EDT 2025 Mon Jul 21 05:51:41 EDT 2025 Tue Jul 01 01:53:47 EDT 2025 Thu Apr 24 22:57:25 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Inflammatory response Daphnetin NF-κb signaling pathway Proliferation Psoriasis |
| Language | English |
| License | Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. This work is licensed under a Creative Commons Attribution 4.0 International License. http://creativecommons.org/licenses/by/4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c636t-f049e710ecbfa5566c1978af57f4d34aa8544a0b75c211bc3e8fef953e2ab3af3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0002-3991-9706 |
| OpenAccessLink | https://doaj.org/article/598eb1b7852d479ab373e27403780203 |
| PMID | 33081840 |
| PQID | 2461841454 |
| PQPubID | 2040165 |
| PageCount | 12 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_598eb1b7852d479ab373e27403780203 scielo_journals_S0716_97602020000100235 pubmedcentral_primary_oai_pubmedcentral_nih_gov_7576854 proquest_miscellaneous_2452980426 proquest_journals_2461841454 gale_infotracmisc_A639018917 gale_infotracacademiconefile_A639018917 gale_incontextgauss_ISR_A639018917 pubmed_primary_33081840 crossref_citationtrail_10_1186_s40659_020_00316_0 crossref_primary_10_1186_s40659_020_00316_0 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2020-10-20 |
| PublicationDateYYYYMMDD | 2020-10-20 |
| PublicationDate_xml | – month: 10 year: 2020 text: 2020-10-20 day: 20 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: Santiago – name: London |
| PublicationTitle | Biological research |
| PublicationTitleAlternate | Biol Res |
| PublicationYear | 2020 |
| Publisher | BioMed Central Ltd BioMed Central Sociedad de Biología de Chile BMC |
| Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: Sociedad de Biología de Chile – name: BMC |
| References | A Di Cesare (316_CR39) 2009; 129 M Li (316_CR17) 2017; 13 S Zhu (316_CR25) 1999; 19 X Liu (316_CR21) 2016; 175 R Dou (316_CR43) 2017; 12 W-H Kim (316_CR40) 2017; 69 M Thewes (316_CR23) 1991; 283 A Kumar (316_CR14) 2016; 82 S Lembo (316_CR36) 2014; 25 KJ Livak (316_CR47) 2001; 25 H Rabeony (316_CR26) 2014; 9 NA Patel (316_CR45) 2009; 14 K Guilloteau (316_CR18) 2010; 184 C Li (316_CR19) 2019; 139 RM Andrés (316_CR10) 2013; 133 MA Lowes (316_CR6) 2013; 34 R Gillitzer (316_CR35) 1993; 101 BS Qazi (316_CR34) 2011; 2011 AB Gottlieb (316_CR32) 2005; 175 MS Hayden (316_CR44) 2008; 132 C Albanesi (316_CR4) 2007; 25 W-w Yu (316_CR15) 2014; 62 JE Greb (316_CR27) 2016; 2 B Song (316_CR30) 2014; 9 Y Wang (316_CR13) 2013; 5 Z Liu (316_CR16) 2016; 44 M Kaštelan (316_CR28) 2009; 17 A Goldminz (316_CR8) 2013; 69 J Sun (316_CR46) 2013; 8 JE Hawkes (316_CR3) 2017; 140 C Albanesi (316_CR5) 2005; 4 Johansen C, Funding AT, Otkjaer K, Kragballe K, Jensen UB, Madsen M, Binderup L, Skak-Nielsen T, Fjording MS, Iversen L (316_CR31) 2006; 176 PF Lizzul (316_CR9) 2005; 124 J An (316_CR41) 2016; 413 R Gillitzer (316_CR33) 1991; 97 H Wang (316_CR42) 2009; 183 WW Yu (316_CR12) 2014; 62 C Chen (316_CR20) 2018; 8 Z He (316_CR11) 2018; 8 L van der Fits (316_CR22) 2009; 182 FO Nestle (316_CR1) 2009; 361 B Korge (316_CR24) 1990; 95 Y Zheng (316_CR38) 2007; 445 MS Hayden (316_CR7) 2004; 18 D Raj (316_CR29) 2006; 126 JR Chan (316_CR37) 2006; 203 WH Boehncke (316_CR2) 2015; 386 Yu, WW; Lu, Z; Zhang, H; Kang, YH; Mao, Y; Wang, HH; Ge, WH; Shi, LY 2014; 62 Rabeony, H; Petit-Paris, I; Garnier, J; Barrault, C; Pedretti, N; Guilloteau, K; Jegou, J-F; Guillet, G; Huguier, V; Lecron, J-C 2014; 9 Patel, NA; Patel, NJ; Patel, RP 2009; 14 Korge, B; Stadler, R; Mischke, D 1990; 95 Guilloteau, K; Paris, I; Pedretti, N; Boniface, K; Juchaux, F; Huguier, V; Guillet, G; Bernard, F-X; Lecron, J-C; Morel, F 2010; 184 Lowes, MA; Russell, CB; Martin, DA; Towne, JE; Krueger, JG 2013; 34 Wang, H; Syrovets, T; Kess, D; Buchele, B; Hainzl, H; Lunov, O; Weiss, JM; Scharffetter-Kochanek, K; Simmet, T 2009; 183 Gillitzer, R; Wolff, K; Tong, D; Müller, C; Yoshimura, T; Hartmann, AA; Stingl, G; Berger, R 1993; 101 Albanesi, C; De Pità, O; Girolomoni, G 2007; 25 Gillitzer, R; Berger, R; Mielke, V; Müller, C; Wolff, K; Stingl, G 1991; 97 Liu, X; Liu, Y; Xu, M; Li, J; Teng, X; Cheng, H; Xia, Y 2016; 175 Hawkes, JE; Chan, TC; Krueger, JG 2017; 140 Di Cesare, A; Di Meglio, P; Nestle, FO 2009; 129 Li, M; Shi, X; Chen, F; Hao, F 2017; 13 van der Fits, L; Mourits, S; Voerman, JS; Kant, M; Boon, L; Laman, JD; Cornelissen, F; Mus, A-M; Florencia, E; Prens, EP 2009; 182 Boehncke, WH; Schön, MP 2015; 386 He, Z; Dong, W; Yao, K; Qin, C; Duan, B 2018; 8 Nestle, FO; Kaplan, DH; Barker, J 2009; 361 An, J; Li, Z; Dong, Y; Ren, J; Huo, J 2016; 413 Wang, Y; Li, CF; Pan, LM; Gao, ZL 2013; 5 Thewes, M; Stadler, R; Korge, B; Mischke, D 1991; 283 Kumar, A; Jha, S; Pattanayak, SP 2016; 82 Chen, C; Wu, N; Duan, Q; Yang, H; Wang, X; Yang, P; Zhang, M; Liu, J; Liu, Z; Shao, Y 2018; 8 Zhu, S; Oh, H-S; Shim, M; Sterneck, E; Johnson, PF; Smart, RC 1999; 19 Song, B; Wang, Z; Liu, Y; Xu, S; Huang, G; Xiong, Y; Zhang, S; Xu, L; Deng, X; Guan, S 2014; 9 Dou, R; Liu, Z; Yuan, X; Xiangfei, D; Bai, R; Bi, Z; Yang, P; Yang, Y; Dong, Y; Su, W 2017; 12 Liu, Z; Liu, J; Zhao, K; Shi, Q; Zuo, T; Wang, G; Wang, W 2016; 44 Sun, J; Zhao, Y; Hu, J 2013; 8 Gottlieb, AB; Chamian, F; Masud, S; Cardinale, I; Abello, MV; Lowes, MA; Chen, F; Magliocco, M; Krueger, JG 2005; 175 Andrés, RM; Montesinos, MC; Navalón, P; Payá, M; Terencio, MC 2013; 133 Yu, W-w; Lu, Z; Zhang, H; Kang, Y-h; Mao, Y; Wang, H-h; Ge, W-h; Shi, L-y 2014; 62 Kim, W-H; An, H-J; Kim, J-Y; Gwon, M-G; Gu, H; Lee, S-J; Park, JY; Park, K-D; Han, S-M; Kim, M-K 2017; 69 Albanesi, C; Scarponi, C; Giustizieri, ML; Girolomoni, G 2005; 4 Hayden, MS; Ghosh, S 2004; 18 Kaštelan, M; Prpić-Massari, L; Brajac, I 2009; 17 Goldminz, A; Au, S; Kim, N; Gottlieb, A; Lizzul, P 2013; 69 Hayden, MS; Ghosh, S 2008; 132 Raj, D; Brash, DE; Grossman, D 2006; 126 Johansen, C; Funding, AT; Otkjaer, K; Kragballe, K; Jensen, UB; Madsen, M; Binderup, L; Skak-Nielsen, T; Fjording, MS; Iversen, L 2006; 176 Livak, KJ; Schmittgen, TD 2001; 25 Qazi, BS; Tang, K; Qazi, A 2011; 2011 Chan, JR; Blumenschein, W; Murphy, E; Diveu, C; Wiekowski, M; Abbondanzo, S; Lucian, L; Geissler, R; Brodie, S; Kimball, AB 2006; 203 Lizzul, PF; Aphale, A; Malaviya, R; Sun, Y; Masud, S; Dombrovskiy, V; Gottlieb, AB 2005; 124 Greb, JE; Goldminz, AM; Elder, JT; Lebwohl, MG; Gladman, DD; Wu, JJ; Mehta, NN; Finlay, AY; Gottlieb, AB 2016; 2 Zheng, Y; Danilenko, DM; Valdez, P; Kasman, I; Eastham-Anderson, J; Wu, J; Ouyang, W 2007; 445 Li, C; Xiao, L; Jia, J; Li, F; Wang, X; Duan, Q; Jing, H; Yang, P; Chen, C; Wang, Q 2019; 139 Lembo, S; Capasso, R; Balato, A; Cirillo, T; Flora, F; Zappia, V; Balato, N; Ingrosso, D; Ayala, F 2014; 25 |
| References_xml | – volume: 133 start-page: 2362 year: 2013 ident: 316_CR10 publication-title: J Invest Dermatol doi: 10.1038/jid.2013.182 – volume: 445 start-page: 648 year: 2007 ident: 316_CR38 publication-title: Nature doi: 10.1038/nature05505 – volume: 14 start-page: 80 year: 2009 ident: 316_CR45 publication-title: Pharm Dev Technol – volume: 126 start-page: 243 year: 2006 ident: 316_CR29 publication-title: J Invest Dermatol doi: 10.1038/sj.jid.5700008 – volume: 175 start-page: 2721 year: 2005 ident: 316_CR32 publication-title: J Immunol doi: 10.4049/jimmunol.175.4.2721 – volume: 19 start-page: 7181 year: 1999 ident: 316_CR25 publication-title: Mol Cell Biol doi: 10.1128/MCB.19.10.7181 – volume: 82 start-page: 439 year: 2016 ident: 316_CR14 publication-title: Biomed Pharm doi: 10.1016/j.biopha.2016.05.028 – volume: 182 start-page: 5836 year: 2009 ident: 316_CR22 publication-title: J Immunol doi: 10.4049/jimmunol.0802999 – volume: 9 start-page: e101937 year: 2014 ident: 316_CR26 publication-title: PLoS ONE doi: 10.1371/journal.pone.0101937 – volume: 62 start-page: 12315 year: 2014 ident: 316_CR12 publication-title: J Agric Food Chem doi: 10.1021/jf503667v – volume: 12 start-page: e0176823 year: 2017 ident: 316_CR43 publication-title: PLoS ONE doi: 10.1371/journal.pone.0176823 – volume: 8 start-page: 34483 year: 2018 ident: 316_CR11 publication-title: RSC Adv doi: 10.1039/C8RA05583A – volume: 101 start-page: 127 year: 1993 ident: 316_CR35 publication-title: J Invest Dermatol doi: 10.1111/1523-1747.ep12363613 – volume: 132 start-page: 344 year: 2008 ident: 316_CR44 publication-title: Cell doi: 10.1016/j.cell.2008.01.020 – volume: 69 start-page: 1030 year: 2017 ident: 316_CR40 publication-title: Pharmacol Rep doi: 10.1016/j.pharep.2017.04.006 – volume: 17 start-page: 182 year: 2009 ident: 316_CR28 publication-title: Acta Dermatovenerol Croat – volume: 44 start-page: 149 year: 2016 ident: 316_CR16 publication-title: Am J Chin Med doi: 10.1142/S0192415X16500105 – volume: 140 start-page: 645 year: 2017 ident: 316_CR3 publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2017.07.004 – volume: 386 start-page: 983 year: 2015 ident: 316_CR2 publication-title: Lancet doi: 10.1016/S0140-6736(14)61909-7 – volume: 9 start-page: e96502 year: 2014 ident: 316_CR30 publication-title: PLoS ONE doi: 10.1371/journal.pone.0096502 – volume: 361 start-page: 496 year: 2009 ident: 316_CR1 publication-title: New Engl J Med doi: 10.1056/NEJMra0804595 – volume: 183 start-page: 4755 year: 2009 ident: 316_CR42 publication-title: J Immunol doi: 10.4049/jimmunol.0900521 – volume: 25 start-page: 581 year: 2007 ident: 316_CR4 publication-title: Clin Dermatol doi: 10.1016/j.clindermatol.2007.08.013 – volume: 4 start-page: 329 year: 2005 ident: 316_CR5 publication-title: Curr Drug Targets Inflamm Allergy doi: 10.2174/1568010054022033 – volume: 18 start-page: 2195 year: 2004 ident: 316_CR7 publication-title: Genes Dev doi: 10.1101/gad.1228704 – volume: 69 start-page: 89 year: 2013 ident: 316_CR8 publication-title: J Dermatol Sci doi: 10.1016/j.jdermsci.2012.11.002 – volume: 8 start-page: e67078 year: 2013 ident: 316_CR46 publication-title: PLoS ONE doi: 10.1371/journal.pone.0067078 – volume: 5 start-page: 1770 year: 2013 ident: 316_CR13 publication-title: Exp Ther Med doi: 10.3892/etm.2013.1054 – volume: 139 start-page: 71 year: 2019 ident: 316_CR19 publication-title: J Invest Dermatol doi: 10.1016/j.jid.2018.06.184 – volume: 2 start-page: 16082 year: 2016 ident: 316_CR27 publication-title: Nat Rev Dis Prim doi: 10.1038/nrdp.2016.82 – volume: 13 start-page: 455 year: 2017 ident: 316_CR17 publication-title: Exp Ther Med doi: 10.3892/etm.2016.3971 – volume: 184 start-page: 5263 year: 2010 ident: 316_CR18 publication-title: J Immunol doi: 10.4049/jimmunol.0902464 – volume: 2011 start-page: 908468 year: 2011 ident: 316_CR34 publication-title: Int J Inflammat doi: 10.4061/2011/908468 – volume: 203 start-page: 2577 year: 2006 ident: 316_CR37 publication-title: J Exp Med doi: 10.1084/jem.20060244 – volume: 25 start-page: 83 year: 2014 ident: 316_CR36 publication-title: J Dermatol Treat doi: 10.3109/09546634.2013.782091 – volume: 95 start-page: 450 year: 1990 ident: 316_CR24 publication-title: J Invest Dermatol doi: 10.1111/1523-1747.ep12555613 – volume: 176 start-page: 1431 year: 2006 ident: 316_CR31 publication-title: J Immunol doi: 10.4049/jimmunol.176.3.1431 – volume: 124 start-page: 1275 year: 2005 ident: 316_CR9 publication-title: J Invest Dermatol doi: 10.1111/j.0022-202X.2005.23735.x – volume: 413 start-page: 87 year: 2016 ident: 316_CR41 publication-title: Mol Cell Biochem doi: 10.1007/s11010-015-2641-6 – volume: 97 start-page: 73 year: 1991 ident: 316_CR33 publication-title: J Invest Dermatol doi: 10.1111/1523-1747.ep12478128 – volume: 8 start-page: 8590 year: 2018 ident: 316_CR20 publication-title: Scientific Rep doi: 10.1038/s41598-018-26996-z – volume: 129 start-page: 1339 year: 2009 ident: 316_CR39 publication-title: J Investigat Dermatol doi: 10.1038/jid.2009.59 – volume: 175 start-page: 314 year: 2016 ident: 316_CR21 publication-title: Br J Dermatol doi: 10.1111/bjd.14481 – volume: 62 start-page: 12315 year: 2014 ident: 316_CR15 publication-title: J Agric Food Chem doi: 10.1021/jf503667v – volume: 283 start-page: 465 year: 1991 ident: 316_CR23 publication-title: Arch Dermatol Res doi: 10.1007/BF00371784 – volume: 25 start-page: 402 year: 2001 ident: 316_CR47 publication-title: Methods doi: 10.1006/meth.2001.1262 – volume: 34 start-page: 174 year: 2013 ident: 316_CR6 publication-title: Trends Immunol doi: 10.1016/j.it.2012.11.005 – volume: 82 start-page: 439 year: 2016 end-page: 448 article-title: Daphnetin ameliorates 7,12-dimethylbenz[a]anthracene-induced mammary carcinogen-esis through Nrf-2-Keap1 and NF-kappaB pathways publication-title: Biomed Pharm – volume: 97 start-page: 73 year: 1991 end-page: 79 article-title: Upper keratinocytes of psoriatic skin lesions express high levels of NAP-1/IL-8 mRNA in situ publication-title: J Invest Dermatol – volume: 283 start-page: 465 year: 1991 end-page: 471 article-title: Normal psoriatic epidermis expression of hyperproliferation-associated keratins publication-title: Arch Dermatol Res – volume: 4 start-page: 329 year: 2005 end-page: 334 article-title: Keratinocytes in inflammatory skin diseases publication-title: Curr Drug Targets Inflamm Allergy – volume: 62 start-page: 12315 year: 2014 end-page: 12325 article-title: Anti-inflammatory and protective properties of daphnetin in endotoxin-induced lung injury publication-title: J Agric Food Chem – volume: 413 start-page: 87 year: 2016 end-page: 95 article-title: Amentoflavone protects against psoriasis-like skin lesion through suppression of NF-κB-mediated inflammation and keratinocyte proliferation publication-title: Mol Cell Biochem – volume: 62 start-page: 12315 year: 2014 end-page: 12325 article-title: anti-inflammatory and protective properties of daphnetin in endotoxin-induced lung injury publication-title: J Agric Food Chem – volume: 69 start-page: 1030 year: 2017 end-page: 1035 article-title: Apamin inhibits TNF-α-and IFN-γ-induced inflammatory cytokines and chemokines via suppressions of NF-κB signaling pathway and STAT in human keratinocytes publication-title: Pharmacol Rep – volume: 386 start-page: 983 year: 2015 end-page: 994 article-title: Psoriasis publication-title: Lancet – volume: 69 start-page: 89 year: 2013 end-page: 94 article-title: NF-κB: an essential transcription factor in psoriasis publication-title: J Dermatol Sci – volume: 184 start-page: 5263 year: 2010 end-page: 5270 article-title: Skin inflammation induced by the synergistic action of IL-17A, IL-22, oncostatin M, IL-1α, and TNF-α recapitulates some features of psoriasis publication-title: J Immunol – volume: 44 start-page: 149 year: 2016 end-page: 163 article-title: Role of daphnetin in rat severe acute pancreatitis through the regulation of TLR4/NF-κ B signaling pathway activation publication-title: Am J Chin Med – volume: 8 start-page: 8590 year: 2018 end-page: 8590 article-title: C10orf99 contributes to the development of psoriasis by promoting the proliferation of keratinocytes publication-title: Scientific Rep – volume: 140 start-page: 645 year: 2017 end-page: 653 article-title: Psoriasis pathogenesis and the development of novel targeted immune therapies publication-title: J Allergy Clin Immunol – volume: 124 start-page: 1275 year: 2005 end-page: 1283 article-title: Differential expression of phosphorylated NF-κB/RelA in normal and psoriatic epidermis and downregulation of NF-κB in response to treatment with etanercept publication-title: J Invest Dermatol – volume: 129 start-page: 1339 year: 2009 end-page: 1350 article-title: The IL-23/Th17 axis in the immunopathogenesis of psoriasis publication-title: J Investigat Dermatol – volume: 8 year: 2013 article-title: Curcumin inhibits imiquimod-induced psoriasis-like inflammation by inhibiting IL-1beta and IL-6 production in mice publication-title: PLoS ONE – volume: 126 start-page: 243 year: 2006 end-page: 257 article-title: Keratinocyte apoptosis in epidermal development and disease publication-title: J Invest Dermatol – volume: 25 start-page: 581 year: 2007 end-page: 588 article-title: Resident skin cells in psoriasis: a special look at the pathogenetic functions of keratinocytes publication-title: Clin Dermatol – volume: 101 start-page: 127 year: 1993 end-page: 131 article-title: MCP-1 mRNA expression in basal keratinocytes of psoriatic lesions publication-title: J Invest Dermatol – volume: 19 start-page: 7181 year: 1999 end-page: 7190 article-title: C/EBPβ modulates the early events of keratinocyte differentiation involving growth arrest and keratin 1 and keratin 10 expression publication-title: Mol Cell Biol – volume: 13 start-page: 455 year: 2017 end-page: 460 article-title: Daphnetin inhibits inflammation in the NZB/WF1 systemic lupus erythematosus murine model via inhibition of NF-κB activity publication-title: Exp Ther Med – volume: 12 year: 2017 article-title: PAMs ameliorates the imiquimod-induced psoriasis-like skin disease in mice by inhibition of translocation of NF-kappaB and production of inflammatory cytokines publication-title: PLoS ONE – volume: 34 start-page: 174 year: 2013 end-page: 181 article-title: The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses publication-title: Trends Immunol – volume: 18 start-page: 2195 year: 2004 end-page: 2224 article-title: Signaling to NF-κB publication-title: Genes Dev – volume: 139 start-page: 71 year: 2019 end-page: 80 article-title: Cornulin is induced in psoriasis lesions and promotes keratinocyte proliferation via phosphoinositide 3-Kinase/Akt pathways publication-title: J Invest Dermatol – volume: 14 start-page: 80 year: 2009 end-page: 89 article-title: Formulation and evaluation of curcumin gel for topical application publication-title: Pharm Dev Technol – volume: 133 start-page: 2362 year: 2013 end-page: 2371 article-title: NF-κB and STAT3 inhibition as a therapeutic strategy in psoriasis: in vitro and in vivo effects of BTH publication-title: J Invest Dermatol – volume: 176 start-page: 1431 year: 2006 end-page: 1438 article-title: Protein expression of TNF-α in psoriatic skin is regulated at a posttranscriptional level by MAPK-activated protein kinase 2 publication-title: J Immunol – volume: 203 start-page: 2577 year: 2006 end-page: 2587 article-title: IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2–dependent mechanisms with implications for psoriasis pathogenesis publication-title: J Exp Med – volume: 8 start-page: 34483 year: 2018 end-page: 34490 article-title: Daphnetin inhibits proliferation and glycolysis in colorectal cancer cells by regulating the PI3K/Akt signaling pathway publication-title: RSC Adv – volume: 2 start-page: 16082 year: 2016 end-page: 16082 article-title: Psoriasis publication-title: Nat Rev Dis Prim – volume: 183 start-page: 4755 year: 2009 end-page: 4763 article-title: Targeting NF-kappa B with a natural triterpenoid alleviates skin inflammation in a mouse model of psoriasis publication-title: J Immunol – volume: 5 start-page: 1770 year: 2013 end-page: 1774 article-title: 7,8-Dihydroxycoumarin inhibits A549 human lung adenocarcinoma cell proliferation by inducing apoptosis via suppression of Akt/NF-kappaB signaling publication-title: Exp Ther Med – volume: 175 start-page: 314 year: 2016 end-page: 324 article-title: Zinc finger protein A20 is involved in the antipsoriatic effect of calcipotriol publication-title: Br J Dermatol – volume: 17 start-page: 182 year: 2009 end-page: 186 article-title: Apoptosis in psoriasis publication-title: Acta Dermatovenerol Croat – volume: 132 start-page: 344 year: 2008 end-page: 362 article-title: Shared principles in NF-κB signaling publication-title: Cell – volume: 25 start-page: 83 year: 2014 end-page: 86 article-title: MCP-1 in psoriatic patients: effect of biological therapy publication-title: J Dermatol Treat – volume: 182 start-page: 5836 year: 2009 end-page: 5845 article-title: Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis publication-title: J Immunol – volume: 95 start-page: 450 year: 1990 end-page: 455 article-title: Effect of retinoids on hyperproliferationassociated keratins K6 and K16 in cultured human keratinocytes: a quantitative analysis publication-title: J Invest Dermatol – volume: 361 start-page: 496 year: 2009 end-page: 509 article-title: Psoriasis publication-title: New Engl J Med – volume: 25 start-page: 402 year: 2001 end-page: 408 article-title: Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method publication-title: Methods – volume: 9 year: 2014 article-title: Inhibition of keratinocyte differentiation by the synergistic effect of IL-17A, IL-22, IL-1α TNFα and oncostatin M publication-title: PLoS ONE – volume: 9 year: 2014 article-title: Immunosuppressive activity of daphnetin, one of coumarin derivatives, is mediated through suppression of NF-κB and NFAT signaling pathways in mouse T cells publication-title: PLoS ONE – volume: 175 start-page: 2721 year: 2005 end-page: 2729 article-title: TNF inhibition rapidly down-regulates multiple proinflammatory pathways in psoriasis plaques publication-title: J Immunol – volume: 2011 start-page: 908468 year: 2011 end-page: 908468 article-title: Recent advances in underlying pathologies provide insight into interleukin-8 expression-mediated inflammation and angiogenesis publication-title: Int J Inflammat – volume: 445 start-page: 648 year: 2007 end-page: 648 article-title: Interleukin-22, a T H 17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis publication-title: Nature |
| SSID | ssj0025026 |
| Score | 2.5551488 |
| Snippet | Psoriasis is a common chronic inflammatory skin disease. Keratinocytes hyperproliferation and excessive inflammatory response contribute to psoriasis... Background Psoriasis is a common chronic inflammatory skin disease. Keratinocytes hyperproliferation and excessive inflammatory response contribute to... Abstract Background: Psoriasis is a common chronic inflammatory skin disease. Keratinocytes hyperproliferation and excessive inflammatory response contribute... Abstract Background Psoriasis is a common chronic inflammatory skin disease. Keratinocytes hyperproliferation and excessive inflammatory response contribute to... |
| SourceID | doaj scielo pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 48 |
| SubjectTerms | Adjuvants, Immunologic - adverse effects Analysis Animals Anti-Inflammatory Agents - pharmacology Antiviral drugs Apoptosis BIOLOGY Cell growth Cell Proliferation Cell viability Cholecystokinin Cytokines Daphnetin Dermatologic agents Dermatology Erythema Formulae, receipts, prescriptions Humans IL-1β Imiquimod Imiquimod - adverse effects Immunofluorescence Inflammation Inflammation - drug therapy Inflammatory response Interleukin 22 Interleukin 6 Interleukin 8 Keratin Keratinocytes Mice Mice, Inbred BALB C Monocyte chemoattractant protein 1 mRNA NF-κB protein NF-κb signaling pathway Nuclear nonproliferation Nuclear transport Oncostatin M Pathogenesis Phosphorylation Proliferation Psoriasis Psoriasis - chemically induced Psoriasis - drug therapy Rabbits RNA Signal transduction Skin Skin diseases Skin lesions Tumor necrosis factor Tumor necrosis factor-α Umbelliferones - pharmacology Western blotting |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELbQCiQuiDeBBRmEtAcUbZvYjnNcFlaFAwd2V9qb5fhBo6ZJ2bSH_S_8WGbstDQgwYVj40fjmfHMfLH9mZC3WWZwtcqk0mYAUDRgVglRM3XWisp7Z40NbJ9fxOySfb7iV3tXfeGesEgPHAV3zEsJ7qQqJM8sK0pd5UXuAEpN8kLiKhp6X4h5WzA1QC0O0GJ7REaK457h8mGKUAmtGDD0KAwFtv4_ffJeUPp9w-RtjE_Nfig6u0_uDTkkPYnv_oDccu1DcifeKnnziPz4oFfzFo8y07qd11W97ukKL-fxLqqb6tZCkQdjWIZFdnodd8o6eErDrX10pk_1BV2EFm1nbiAjDc300jV4qh9_18v6-wZ0bVMA9mAilq76Dgy6r_u0qReO9gvor3H4QQ57XoJTekwuzz5enM7S4RKG1IhcrFMPEMJBGuJM5TWH5M9MAXhqzwvPbM60lpyBiquCG8CSlcmd9M6XHJQEutI-f0IO2q51zwiFzEKAg_TWl5Jpw2QJwZBZXRltJlnlEzLd6kSZgaEcL8poVEAqUqioRwV6DJymQk0S8m7XZhX5Of5a-z2qelcTubXDA7A4NVic-pfFJeQNGopC9owWt-d805u-V5_Ov6oTgZ-QJEDghBwNlXwHY4ARxtMOIAkk3BrVPBzVhOltxsVbe1SDe-kVkgBKNmWcJeT1rhhb4pa51nUbrMOzUiJETsjTaL67cec5MhkykEcxMuyRYMYlbT0P5OMFAlT836M4BX691Dlkq0JBegtCysKqUSBTev4_ZP6C3MVOMWnIJofkYH29cS8hG1xXr8LE_wnkXloF priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELaggMSl4llSCjIIqQcUNZvYiXNCpVAtHDjQVtqb5fjRjTabbDe7h_4XfiwzTna3AanHjcfZ2J7xzOfHN4R8imONu1U6FCYGgKIAswrwmqE1Ji2cs0Ybz_b5Kx1fsZ8TPukX3Nr-WOVmTvQTtWk0rpGfIO-ZYCPG2ZfFTYhZo3B3tU-h8ZA8QuoyPNKVTXaAi0c-3Rp40TQEtxttLs2I9KRluKEYInhCvQZUPXBMnr___1n6jpv69wjlY_RY1V3ndP6M7PdRJT3t1OA5eWDrF-RJl2fy9iX5800tpjVebqZlPS2LctXSBabrcbZTAKpqA0UO1GPut93psjs7a-Ep9Xn86FidqUs68zXqRt9CjOqrqbmt8J4__i7n5c0aRt-EAPVBaQxdtNCJqi3bsCpnlrYzeF9lcYkO3zyHaeoVuTr_fnk2Dvu0DKFOk3QVOgAVFgITqwunOISDegRQVDmeOWYSppTgDAa9yLgGdFnoxApnXc4TG6siUS55TfbqprZvCIVYI4Up0xmXC6Y0Ezm4R2ZUoZWO4sIFZLQZE6l7znJMnVFJj11EKrtxlDCOnuU0lVFAPm_rLDrGjnulv-JQbyWRbds_aJbXsjdeyXMBLq3IBI8Ny3JoRQaNyViUZAJ3cgPyERVFIp9GjQd2rtW6beWPi9_yNMVFJQGgOCDHvZBroA3Qwu7-A_QEUnANJI8GkmDweli80UfZTzit3JlHQD5si7EmHqKrbbNGGR7nAkFzQA469d22O0mQ25BBf2QDxR50zLCkLqeejjxDyIr_e9yZwO6jLtDyJFpeHMV-H8nTKx3e34C35CmKY4AQR0dkb7Vc23cQ-a2K9968_wKbVFUg priority: 102 providerName: ProQuest |
| Title | Daphnetin inhibits proliferation and inflammatory response in human HaCaT keratinocytes and ameliorates imiquimod-induced psoriasis-like skin lesion in mice |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/33081840 https://www.proquest.com/docview/2461841454 https://www.proquest.com/docview/2452980426 https://pubmed.ncbi.nlm.nih.gov/PMC7576854 http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602020000100235&lng=en&tlng=en https://doaj.org/article/598eb1b7852d479ab373e27403780203 |
| Volume | 53 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELf2ARIviG8CowoIaQ8orE2cxHlAqBubSiUmtK7S3izHH2vUNOmaVqL_C38sd05aFpgQT1Xjc1qf73z389l3hLz3fYnRKukx5QNAEYBZGVhNTysVpcZoJZXN9nkeDcZ0eBVe7ZBNuaOGgdWd0A7rSY0X-ccfN-vPoPCfrMKz6KiiGBz0EAihjAJC3iX7YJliVNRvdBtVAGtvy68hhPEigAqbSzR3vqNlqGw-_79X7Vtm688jlffQguW3jdXZI_Kw8TLdfi0Wj8mOLp6Q-3XdyfVT8vOLmE8KvOzsZsUkS7Nl5c6xfI_RtUC4olDQZEBcZjYM7y7qs7Qanrq2rp87ECfi0p3aHkUp1-Cz2m5ipnO894_fs1l2swJpUB5AfxAi5c6rEkS-yiovz6barabwvlzjlh2-eQbL1jMyPju9PBl4TZkGT0ZBtPQMgAwNjoqWqREhuIeyB9BUmDA2VAVUCBZSEII0DiWgzVQGmhltkjDQvkgDYYLnZK8oC_2SuOB7RLCEGmUSRoWkLAFzSZVIpZBdPzUO6W3mhMsmhzmW0si5xTIs4vU8cphHm_U04l2HfNj2mdcZPP5JfYxTvaXE7Nv2Qbm45o0y8zBhYOLSmIW-onECo4hhMDHtBjHDyK5D3qGgcMyvUeABnmuxqir-dXTB-xFuMjEAyQ45bIhMCWOAEdb3IYATmJKrRXnQooQFQLabN_LIN_rDMU0goz0aUoe83TZjTzxUV-hyhTShnzAE0Q55UYvvdtxBgLkOKfAjbgl2izHtliKb2PTkMUJY_N3DWgV-_6kRaF7EwQEGJvk2rmTTLb36b068Jg-wJ_oOfveA7C0XK_0GnMJl2iG78VXcIfv9_nA0hM_j0_PvFx27xdKxq8AvNz9hbQ |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Jb9NAFB6VFAQXxE6ggEGgHpBVxx7b4wNCXZXQEqEuUm_DeJbGSuKkcSKU_8Jv4Dfy3thOa5B66zGeGcdv3vrN8h4hH31f4m6VdJnyAaAIwKwMvKarlYpSY7SSymb77EfdM_rtPDxfI3_quzB4rLK2idZQq4nENfItzHvGaIeG9Ov00sWqUbi7WpfQKMXiUC9_AWQrvvT2gL-ffP9g_3S361ZVBVwZBdHcNRATa_CrWqZGhBDNyA4gKWHC2FAVUCFYSOGb0ziUAI5SGWhmtEnCQPsiDYQJ4L13yDoNAMq0yPrOfv_H8QrihZ4t8AZ-O3LB0Xv1NR0WbRUUtzBdhGuoSYDjG67QVgz43y9cc4z_Htq8iz5ydN0dHjwiD6s41tkuBe8xWdP5E3KvrGy5fEp-74npIMfr1E6WD7I0mxfOFAsEGV2KnCNyBU0GBHJsN_qdWXlaV8NTx1YOdLpiV5w6Qzsin8glRMV2mBjrEWYWwN_ZOLtcgLwpN8sViKlypgWwTRRZ4Y6yoXaKIbxvpHFREN88BsP4jJzdCsuek1Y-yfVL4kB0E4GRNsokjApJWQIOmSqRSiE9PzVt0ql5wmWVJR2LdYy4RUss4iUfOfDR5lWNuNcmn1djpmWOkBt77yCrVz0xv7d9MJld8Mpc8DBh4ETTmIW-onECVMRATEy9IGa4d9wmH1BQOGbwyPGI0IVYFAXvnRzz7QiXsRjA8DbZrDqZCdAAFJY3LmAmMOlXo-dGoyeYGNlsruWRVyau4FcK2SbvV804Eo_t5XqywD6hnzCE6W3yohTfFd1BgNkUKcxH3BDsxsQ0W_JsYBOgxwiS8X83SxW4-qgT1DyOmud7vt25sgmdXt1MwDtyv3v6_Ygf9fqHr8kDHIrhie9tkNZ8ttBvIO6cp28rZXfIz9u2L38BDR-Upw |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Daphnetin+inhibits+proliferation+and+inflammatory+response+in+human+HaCaT+keratinocytes+and+ameliorates+imiquimod-induced+psoriasis-like+skin+lesion+in+mice&rft.jtitle=Biological+research&rft.au=Gao%2C+Jintao&rft.au=Chen%2C+Fangru&rft.au=Fang%2C+Huanan&rft.au=Mi%2C+Jing&rft.date=2020-10-20&rft.pub=BioMed+Central+Ltd&rft.issn=0717-6287&rft.volume=53&rft.issue=1&rft_id=info:doi/10.1186%2Fs40659-020-00316-0&rft.externalDocID=A639018917 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0717-6287&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0717-6287&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0717-6287&client=summon |